The FY2025 (Dec) proxy of Sutro Biopharma names 18 peer companies for pay. Pay versus performance data of Sutro Biopharma for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Arcus Biosciences | ||
| Zymeworks | ||
| Nurix Therapeutics | ||
| Kura Oncology | ||
| Replimune Group | ||
| Gossamer Bio | ||
| Alector | Not disclosed | Not disclosed |
| Allogene Therapeutics | Not disclosed | Not disclosed |
| Anaptys Bio, Inc. | Not disclosed | Not disclosed |
| Atara Biotherapeutics, Inc. | Not disclosed | Not disclosed |
| Caribou Biosciences | Not disclosed | Not disclosed |
| G1 Therapeutics, Inc. | Not disclosed | Not disclosed |
| Gritstone Bio, Inc. | Not disclosed | Not disclosed |
| IGM Biosciences, Inc. | Not disclosed | Not disclosed |
| Macrogenics | Not disclosed | Not disclosed |
| Mersana Therapeutics, Inc. | Not disclosed | Not disclosed |
| Poseida Therapeutics, Inc. | Not disclosed | Not disclosed |
| Sangamo Therapeutics, Inc. | Not disclosed | Not disclosed |
'%20fill='%23224a7c'/%3e%3c/clipPath%3e%3cclipPath%20id='clip-path-2'%3e%3cpath%20id='Path_4394'%20d='M4.892,12.4c.758.192,1.629.412,2.67.6a27,27,0,0,0,5.02.426,18.387,18.387,0,0,0,4.07-.6,15.613,15.613,0,0,1,3.2-.6,2.179,2.179,0,0,1,1.861.814,3.668,3.668,0,0,1,.542,1.724c.058.524.058.872.35,1.086a3.609,3.609,0,0,0,1.821.31c.95.02,2.268-.02,3.12-.058s1.24-.077,1.531.1a1.153,1.153,0,0,1,.485.989,10.163,10.163,0,0,0-.136,1.3,2.4,2.4,0,0,0,.717,1.142,4.087,4.087,0,0,1,.872,1.222.844.844,0,0,1-.446,1.066,5.765,5.765,0,0,1-2.171.5,10.913,10.913,0,0,0-2.326.271c-.465.194-.426.581-.155.988s.776.833,1.028,1.3a1.084,1.084,0,0,1-.136,1.357,4.056,4.056,0,0,1-1.977.814c-.814.155-1.667.194-2.442.329a12.864,12.864,0,0,0-1.978.543c-.5.175-.814.291-.969.621a.85.85,0,0,0,.427,1.163,13.866,13.866,0,0,0,2.616.5c.872.175,1.453.484,1.55,1.047a13.544,13.544,0,0,1-.368,2.229,3.628,3.628,0,0,0,.523,2.267,1.967,1.967,0,0,0,1.589.755,8,8,0,0,0,2.364-.077,8.558,8.558,0,0,0,1.822-.736,1.836,1.836,0,0,1,1.861-.1,4.294,4.294,0,0,1,1.182,2.326c.194.872.155,1.569.891,2.015a14.815,14.815,0,0,0,3.664.93A14,14,0,0,1,41.4,42.242a9.687,9.687,0,0,1,1.736,1.229A24.91,24.91,0,1,0,4.892,12.4'%20transform='translate(-4.892%20-0.176)'%20fill='%23224a7c'/%3e%3c/clipPath%3e%3c/defs%3e%3cg%20id='Group_3541'%20transform='translate(-0.094%20-0.128)'%3e%3cg%20id='Group_3282'%20transform='translate(0.094%2015.73)'%3e%3cg%20id='Group_3281'%20clip-path='url(%23clip-path)'%3e%3crect%20id='Rectangle_2848'%20width='33.837'%20height='20.982'%20transform='translate(-0.094%2033.75)%20rotate(-89.841)'%20fill='%23224a7c'/%3e%3c/g%3e%3c/g%3e%3cg%20id='Group_3284'%20transform='translate(3.563%200.128)'%3e%3cg%20id='Group_3283'%20clip-path='url(%23clip-path-2)'%3e%3crect%20id='Rectangle_2849'%20width='43.423'%20height='46.468'%20transform='translate(-0.12%2043.294)%20rotate(-89.841)'%20fill='%23224a7c'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
18 companies
Changes by year
FY2025 (Dec) proxy
- AddedCaribou Biosciencespay peer groupfollowing companies were removed due to acquisition or wind-down of those organizations: Alaunos Therapeutics, Inc., ImmunoGen, Inc
- AddedPoseida Therapeutics, Inc.pay peer groupfollowing companies were removed due to acquisition or wind-down of those organizations: Alaunos Therapeutics, Inc., ImmunoGen, Inc
- RemovedAlaunos Therapeutics, Inc.pay peer groupfollowing companies were removed due to acquisition or wind-down of those organizations: Alaunos Therapeutics, Inc., ImmunoGen, Inc
- RemovedImmunoGen, Inc.pay peer groupfollowing companies were removed due to acquisition or wind-down of those organizations: Alaunos Therapeutics, Inc., ImmunoGen, Inc
FY2024 (Dec) proxy
- AddedIGMpay peer groupTwo companies that fit the Compensation Committee’s desired criteria and had market capitalization on July 17, 2023 ranging from $475 million to $597 million were added to the 2024 Peer Group: IGM biosciences and Nurix Therapeutics
- AddedNurix Therapeuticspay peer groupTwo companies that fit the Compensation Committee’s desired criteria and had market capitalization on July 17, 2023 ranging from $475 million to $597 million were added to the 2024 Peer Group: IGM biosciences and Nurix Therapeutics
- RemovedChemoCentryxpay peer groupfollowing acquisition of those organizations: ChemoCentryx and Clovis Oncology
- RemovedClovis Oncologypay peer groupfollowing acquisition of those organizations: ChemoCentryx and Clovis Oncology
FY2023 (Dec) proxy
- RemovedCytokineticspay peer groupfollowing companies with larger market capitalization than Sutro were removed from the 2023 Peer Group to better-align the group’s overall market capitalization with Sutro’s: Cytokinetics, Denali Therapeutics
- RemovedDenali Therapeuticspay peer groupfollowing companies with larger market capitalization than Sutro were removed from the 2023 Peer Group to better-align the group’s overall market capitalization with Sutro’s: Cytokinetics, Denali Therapeutics
- RemovedFate Therapeuticspay peer groupfollowing companies with larger market capitalization than Sutro were removed from the 2023 Peer Group to better-align the group’s overall market capitalization with Sutro’s: Cytokinetics, Denali Therapeutics
- RemovedOdonate Therapeuticspay peer groupbecause it was delisted
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.